[
    "{\"step_by_step_thinking\": \"Nivolumab, also known as Opdivo, is a medication used in cancer treatment. It is a type of immunotherapy that works by inhibiting the programmed cell death protein 1 (PD-1), not PD-L1. Therefore, it is not a PD-L1 inhibitor.\", \"answer_choice\": \"B. no\"}"
]